Durham.

PositionTriangle

DURHAM--Drug developer Aldagen withdrew plans for an initial public offering. The company, which had hoped to raise $80.5 million, cited poor market conditions.

For a daily roundup of business news in the Triangle region, go...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT